By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences disclosed in a filing today with the US Securities and Exchange Commission that it has received a notice from the Nasdaq Stock Market that it did not achieve compliance with the $1 bid price requirement under listing rules by Feb. 13, 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: method to detect single-nucleotide and copy-number alterations in single cells from archival tissue, and more.

China has announced new rules governing the use of stem cell treatments, Nature News reports.

Wired's Sarah Zhang expresses frustration as a microbiome study of homes uncovers expected bacteria.

A database containing genome sequences from strains of foodborne pathogens may enable regulators and companies to quickly identify outbreak sources, Reuters reports.